CN104273579A - Healthcare enteromorpha prolifera capsules - Google Patents
Healthcare enteromorpha prolifera capsules Download PDFInfo
- Publication number
- CN104273579A CN104273579A CN201310290485.8A CN201310290485A CN104273579A CN 104273579 A CN104273579 A CN 104273579A CN 201310290485 A CN201310290485 A CN 201310290485A CN 104273579 A CN104273579 A CN 104273579A
- Authority
- CN
- China
- Prior art keywords
- enteromorpha
- sea
- tangle
- healthcare
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 19
- 241000196253 Ulva prolifera Species 0.000 title abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- 241000196252 Ulva Species 0.000 claims description 32
- 239000012141 concentrate Substances 0.000 claims description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 244000194101 Ginkgo biloba Species 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000007598 dipping method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000002532 grape seed extract Nutrition 0.000 claims description 5
- 229940087603 grape seed extract Drugs 0.000 claims description 5
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000020995 raw meat Nutrition 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 235000012000 cholesterol Nutrition 0.000 abstract description 12
- 206010020772 Hypertension Diseases 0.000 abstract description 11
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 235000013325 dietary fiber Nutrition 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 5
- 239000011707 mineral Substances 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 241000512259 Ascophyllum nodosum Species 0.000 abstract description 3
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 229920001661 Chitosan Polymers 0.000 abstract description 2
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract description 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract 1
- 240000006365 Vitis vinifera Species 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 235000004213 low-fat Nutrition 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 241000370738 Chlorion Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- -1 carbon fatty acid Chemical class 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 206010067997 Iodine deficiency Diseases 0.000 description 3
- 229920001543 Laminarin Polymers 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 235000006479 iodine deficiency Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 102000005862 Angiotensin II Human genes 0.000 description 2
- 101800000733 Angiotensin-2 Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000218628 Ginkgo Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005717 Laminarin Substances 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229950006323 angiotensin ii Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 241000194025 Streptococcus oralis Species 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to healthcare enteromorpha prolifera capsules. The healthcare enteromorpha prolifera capsules are characterized by being prepared from enteromorpha prolifera, kelp, chitosan, a grape pip extract, a ginkgo leaf extract and vitamin C according to certain ratio and processes. Hypertension, hyperglycemia and fatty liver are epidemic diseases at present, and blood fat lowering, cholesterol lowering and blood pressure lowering have become hot topics of the moment. With the continuous increase of the pursuit of quality of life of people, healthy and green foods are favored by more and more people. People have been looking for a natural and green healthcare product which is high in protein, high in dietary fiber, low in fat, low in energy and rich in mineral substances and vitamins and the like. The healthcare enteromorpha prolifera capsules provided by the invention are high in protein, high in dietary fiber, low in fat and low in energy and can be used for controlling cholesterol, inhibiting bacteria and preventing and controlling hypertension, thereby being a purely-natural and green healthcare product with the activity of resisting oxidation, resisting ageing and maintaining beauty and keeping young. The health care needs of a variety of people can be met.
Description
technical fieldthe present invention relates to a kind of Enteromorpha health-caring capsule, it is characterized in that selecting Enteromorpha, sea-tangle, shitosan, grape seed extract, ginkgo biloba p.e, vitamin C to make with technique according to a certain percentage.Hypertension, hyperglycaemia, fatty liver are present epidemic diseases, and reducing blood lipid, norcholesterol, hypotensively to have become when next hot issue.Along with people improve constantly for the pursuit of quality of the life, healthy, green food is more and more subject to the favor of people.People are seeking a kind of high protein, high dietary-fiber, low fat, low-yield always, and are rich in the environmental protective hygienic product such as minerals and vitamins.This patent provides a kind of Enteromorpha health-caring capsule, Enteromorpha sea-tangle meets people for high protein, high dietary-fiber, low fat, low-energy demand, shitosan has control cholesterol, anti-bacteria, prevention and control hypertension, absorption and excretion heavy metal and immune effect, grape pip, ginkgo biloba p.e have activity that is anti-oxidant, anti-ageing, beautifying face and moistering lotion, are a kind of fully natural green health products.The health care demand of multiple crowd can be met.
background technologythe life of modern improves constantly, and causes nutrition unbalanced, and dietary structure is unreasonable; Both pursued and eaten smart, enjoy.Mouth is very popular, and health is influenced, and occurred three high three low symptoms, create hypertension, high fat of blood, hyperglycaemia, obese people constantly increases.High fat of blood is that body inner cholesterol and triglycerides increase, and can cause dizziness, the sclerosis of cardiovascular and cerebrovascular.High fat of blood is certain to cause angiocardiopathy, particularly triglycerides, is independent hazard factor; Have pectoralgia, nervous, these symptoms of atrial fibrillation may have coronary heart disease to be present in, only do not get rid of just arrhythmia cordis, blood fat is high, rubbish in blood is also just many, and result in vessel wall thickening, velocity of blood flow is slow, blood pressure increases, and cardiac insufficiency will cause pained, nervous etc.; General recommendations had better dietotherapy relatively good.Iodine deficiency is a kind of distribution endemic disease very widely, except a few countries such as Norway, Iceland.Countries in the world are subject to the threat of iodine deficiency all to some extent.Current people add some points salt to prevent and treat iodine deficiency mainly through edible.But there is again the hypertensive risk of initiation in edible too much salt.Therefore it is more rational for supplementing the necessary iodine of growth by diet.This Enteromorpha health-caring capsule that the present invention relates to, meet a kind of high protein of people, high dietary-fiber, low fat, low-yield, and be rich in the demand of the environmental protective hygienic product such as minerals and vitamins, decapacitation reducing blood lipid, norcholesterol, treating diabetes, softening blood vessel, supplementing iodine are especially, also there is restoring consciouness of soothing the spirit, help digestion sober up, clearing liver moistening lung, fatigue-relieving, health lengthen one's life, effect of beauty and health care, are a kind of environmental protective hygienic product being applicable to multiple crowd.
summary of the inventionmain points of the present invention are to select suitable component, and carry out reasonable preparation, through a kind of Enteromorpha health-caring capsule of purification, drying, pulverizing, configuration, capsule subpackage.
The formula that the present invention selects is following (component and percentage by weight % thereof): Enteromorpha and sea-tangle (1:1) mixed powder 50.0-60.0, shitosan 10.0-20.0, grape seed extract 5.0-10.0, ginkgo biloba p.e 5.0-10.0, vitamin C 5.0-10.0.
Enteromorpha: Enteromorpha is rich in carbohydrate, protein, crude fibre and mineral matter, simultaneously also containing fat and vitamin.In enteromorpha protein matter, amino acid classes is complete, and essential amino acids content is higher, and wherein the limiting amino acid of edge pipe Enteromorpha is lysine, and AAS is 79; The limiting amino acid of bar Enteromorpha is methionine, and AAS is 80.Enteromorpha aliphatic acid composition in, the content of polyunsaturated fatty acid, monounsaturated fatty acids and saturated fatty acid for being respectively 50.5%, 12.7% and 36.8%, comprising the odd carbon fatty acid of nearly 4%.Therefore Enteromorpha is high protein, high dietary-fiber, low fat, low-yield, and is rich in the raw material of the natural ideal nutritional food of minerals and vitamins.
Sea-tangle: sea-tangle is the vegetables that a kind of nutritive value is very high, compared with spinach, rape, except vitamin C, the content of its crude protein, sugar, calcium, iron all exceeds several times, Ji Shibei.In sea-tangle, alginic acid sodium salt has the effect of pre-preventing leukemia and Itai-itai diseases; Also anastalsis is had to arterial hamorrhage.Sodium alginate has hypotensive effect.Laminarin has the effect reducing blood fat.Also find that a kind of extract of sea-tangle has antitumaous effect.Kelp mannitol is all effective to treatment acute renal decline, encephaledema, second encephalitis, acute glaucoma.Also containing abundant zinc in seaweeds food.In general, the male sex lacks zinc and sperm quantity can be caused to reduce and sperm quality decline, and goes down with property function and reproductive function; Women lacks the symptom such as vaginal fluid minimizing when zinc then may cause sexual intercourse.Thus, the people that can not enjoy " property good fortune " concerning scarce zinc, seaweeds food is potion good medicine.In seaweeds food, sea-tangle has effect of liver-smoothing, qi-regulating.The traditional Chinese medical science is thought, liver and property function close relation, on the one hand, the main feelings will of liver, only in love will is sensible, mechanism of qi is smooth and easy, people could normally generation for and complete sexuality; On the other hand, the main blood of liver, liver blood is sufficient, could supply penis fully, keeps it to erect and strong.From composition, containing some polysaccharide and alcohols in sea-tangle, they have anticoagulant effect, are beneficial to vascular endothelial cell, can prevention of arterial atherosis, thus reduce the generation of erectile dysfunction.Containing a lot of alkaline components in sea-tangle, helpful for acid-base balance in body; Laminaran contained by sea-tangle has eliminates the effect of blood fat, and blood middle cholesterol content can be made greatly to reduce, and laminarin sulfuric acid ester be normally glucide, also can have effect of reducing blood lipid, beneficial for preventing angiocardiopathy like this.From traditional Chinese medical science angle, seawater belongs to sombrely cold and cool, and the sea-tangle being grown on this inherently has extremely strong cold tolerance.Sea-tangle nature and flavor are salty, the long-term edible effect also having temperature compensation kidney qi.Thus, winter, edible kelps, can strengthen the cold-resistant of human body and yang invigorating functions.
Shitosan: effect of shitosan has: 1. control cholesterol.Shitosan has two mechanism to reduce cholesterol.One is the absorption stoping fat, and another is fallen by the Cholesterol Excretion in blood of human body.These two kinds of mechanism make shitosan become strong cholesterol scavenger.Shitosan is a kind of natural material, has powerful Anion-adsorption power, is applicable to reduce cholesterol and without any side effect.2. Antibacterial activity.Shitosan is easy to dissolve in weak acid solvent, it is worthy of note that these amino are by carrying out anti-bacteria in conjunction with negatron containing amino (NH2+) in the solution after dissolving especially.3. prevention and corntrol hypertension.Be exactly chlorion (cl-) to one of the most influential factor of hypertension.It is taken in by salt usually.The all excessive consumption salt of recent many people.Angiotensin converting enzyme (ACE:Angiotensin Converting Enzyme) produces angiotensin II, and one causes vasoconstrictive material, and its vigor is from chlorion.Polymer chitosan plays a role as dietary fiber, is not absorbed in intestines.Shitosan passes through the suction-operated between the chlorion of self and ammonia radical ion, excretion chlorion.Therefore, shitosan reduces angiotensin II.It contributes to preventing hypertension, particularly the crowd of those Excess free enthalpy salt.4. absorption and excretion heavy metal.A remarkable characteristic of shitosan is adsorption capacity.Many low-molecular-weight materials, such as metal ion, cholesterol, triglycerides, cholic acid and organic mercury etc., can be adsorbed by shitosan.Particularly shitosan not only can adsorb magnesium, potassium, and can adsorb zinc, calcium, mercury and uranium.5, immune effect.Shitosan has higher protein adsorption ability; Under the effect of digestive enzyme, shitosan tool degradability; Shitosan is easy to be processed into line, is applicable to the medical material making wire or sheet; Shitosan has affinity and dissolubility, is applicable to produce each analog derivative; Shitosan has higher chemism; The retentiveness of shitosan is high; In serum, shitosan is easily degraded absorption; Shitosan has higher biological degradability; Shitosan shows the effect selectively highly suppressing Streptococcus oralis growth, does not affect the growth of other beneficial bacterias simultaneously.
Grape seed extract: can scavenging free radicals, anti-oxidant; Desalination color spot, skin whitening; Keep skin elasticity, reduce wrinkle; The effect of antiallergy, anti-inflammatory; Develop immunitypty, antitumor, anti-cancer; Protective effect is had to the heart, the cerebrovascular.
Ginkgo biloba p.e: can activating blood circulation to dissipate blood stasis and dredge the collateral.Ginkgo leaf is at present still used for the treatment of memory by Chinese Medicine and loses, stomach pain, dysentery, hypertension, stress and respiratory problems as asthma, bronchitis and the anxiety that is bad and that cause that circulates.The active component of ginkgo is terpenes part, comprising ginkgolides and Bilobalide.These GINKGO BILOBA EXTRACTs-glucoside composition has powerful anti-oxidant and Scavenging ability.
Production technology of the present invention is: and Enteromorpha, sea-tangle → rinsing → de-raw meat → pulverize → add water hot dipping carries → is incubated → and coarse filtration → diatomite filter → vacuum concentration pan → concentrate → concentrate mixes → mixer granulation → drying → sterilizing → capsule subpackage with other auxiliary materials.
The preparation method of product of the present invention is:
1) pretreatment: Enteromorpha, sea-tangle are cleaned, taken off raw meat, chopping, oven dry, and pulverizer is broken into fine powder;
2) hot dipping is extracted: mixing fine powders is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Enteromorpha sea-tangle concentrate;
5) Enteromorpha sea-tangle concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7) irradiate 30 minutes under ultraviolet, then under GMP clean environment, use capsule subpackage.
Tool of the present invention has the following advantages:
1) high protein, high dietary-fiber, low fat, low-yield;
2) cholesterol, anti-bacteria, prevention and control hypertension, absorption and excretion heavy metal is controlled;
3) anti-oxidant, anti-ageing, beautifying face and moistering lotion;
4) eat, carry, store conveniently;
5) crowd is suitable for wide.
detailed description of the inventionbelow in conjunction with embodiment, the present invention is described in further detail:
For 100kg product of the present invention:
1. fill a prescription:
Enteromorpha and sea-tangle (1:1) mixed powder 50.0-60.0, shitosan 10.0-20.0, grape seed extract 5.0-10.0, ginkgo biloba p.e 5.0-10.0, vitamin C 5.0-10.0.
2. production technology:
Enteromorpha, sea-tangle → rinsing → de-raw meat → pulverize → add water hot dipping carries → is incubated → and coarse filtration → diatomite filter → vacuum concentration pan → concentrate → concentrate mixes → mixer granulation → drying → sterilizing → capsule subpackage with other auxiliary materials.
3. production procedure:
1) pretreatment: Enteromorpha, sea-tangle are cleaned, taken off raw meat, chopping, oven dry, and pulverizer is broken into fine powder;
2) hot dipping is extracted: mixing fine powders is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Enteromorpha sea-tangle concentrate;
5) Enteromorpha sea-tangle concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7) irradiate 30 minutes under ultraviolet, then under GMP clean environment, use capsule subpackage.
Claims (3)
1. the present invention relates to a kind of preparation method of Enteromorpha health-caring capsule, it is characterized in that there is following formula (component and percentage by weight % thereof):
Enteromorpha and sea-tangle (1:1) mixed powder 50.0-60.0, shitosan 10.0-20.0, grape seed extract 5.0-10.0, ginkgo biloba p.e 5.0-10.0, vitamin C 5.0-10.0.
2. a preparation method for Enteromorpha health-caring capsule according to claim 1, is characterized in that having following production technology:
Enteromorpha, sea-tangle → rinsing → de-raw meat → pulverize → add water hot dipping carries → is incubated → and coarse filtration → diatomite filter → vacuum concentration pan → concentrate → concentrate mixes → mixer granulation → drying → sterilizing → capsule subpackage with other auxiliary materials.
3. a preparation method for Enteromorpha health-caring capsule according to claim 1, is characterized in that having following preparation method:
1) pretreatment: Enteromorpha, sea-tangle are cleaned, taken off raw meat, chopping, oven dry, and pulverizer is broken into fine powder;
2) hot dipping is extracted: mixing fine powders is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Enteromorpha sea-tangle concentrate;
5) Enteromorpha sea-tangle concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7) irradiate 30 minutes under ultraviolet, then under GMP clean environment, use capsule subpackage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290485.8A CN104273579A (en) | 2013-07-11 | 2013-07-11 | Healthcare enteromorpha prolifera capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290485.8A CN104273579A (en) | 2013-07-11 | 2013-07-11 | Healthcare enteromorpha prolifera capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104273579A true CN104273579A (en) | 2015-01-14 |
Family
ID=52249318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310290485.8A Pending CN104273579A (en) | 2013-07-11 | 2013-07-11 | Healthcare enteromorpha prolifera capsules |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104273579A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124582A (en) * | 2015-09-10 | 2015-12-09 | 青岛银色世纪健康产业集团有限公司 | Capsule having function of antioxidation and preparation method of capsule |
| CN106136064A (en) * | 2016-07-25 | 2016-11-23 | 滨州中裕食品有限公司 | A kind of healthy and nutritious noodle being applicable to hyperlipemic patients crowd |
| CN106307548A (en) * | 2016-09-29 | 2017-01-11 | 防城港市港口区晶通科技有限公司 | Ocean health-care food containing folium ginkgo extractives |
| CN114376233A (en) * | 2022-03-23 | 2022-04-22 | 青岛海大生物集团股份有限公司 | Enteromorpha polysaccharide health food with immunity enhancing function and preparation method thereof |
-
2013
- 2013-07-11 CN CN201310290485.8A patent/CN104273579A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124582A (en) * | 2015-09-10 | 2015-12-09 | 青岛银色世纪健康产业集团有限公司 | Capsule having function of antioxidation and preparation method of capsule |
| CN106136064A (en) * | 2016-07-25 | 2016-11-23 | 滨州中裕食品有限公司 | A kind of healthy and nutritious noodle being applicable to hyperlipemic patients crowd |
| CN106307548A (en) * | 2016-09-29 | 2017-01-11 | 防城港市港口区晶通科技有限公司 | Ocean health-care food containing folium ginkgo extractives |
| CN114376233A (en) * | 2022-03-23 | 2022-04-22 | 青岛海大生物集团股份有限公司 | Enteromorpha polysaccharide health food with immunity enhancing function and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105455047A (en) | Health carp ball and making method thereof | |
| CN106174474A (en) | A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible | |
| CN106118870A (en) | A kind of nourishing healthy Oleum Camelliae | |
| CN104273579A (en) | Healthcare enteromorpha prolifera capsules | |
| CN104799358A (en) | Production method of special-flavored peanut butter | |
| CN103719948A (en) | Medical pork tripe soup capable of tonifying spleen and promoting appetite | |
| CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
| CN102018158A (en) | Aloe jam | |
| CN111467468A (en) | Concentrated nutrient solution containing ginseng, cordyceps militaris, ginger and wolfberry fruit and preparation method thereof | |
| KR20200043555A (en) | Supplement food composition for diet | |
| CN106418274A (en) | Vinegar-processed egg and mushroom nutrition and healthcare chewable tablets and preparation method thereof | |
| CN110679935A (en) | Burdock and ginseng essence cream and preparation method thereof | |
| CN104222802A (en) | Production method of kelp and soybean noodles | |
| KR101800787B1 (en) | The manufacturing method of ginseng dried radish leaf rice | |
| CN104323119B (en) | Composite nutrient enrichment rice with functions of resisting fatigue and improving memory, and preparation method of composite nutrient enrichment rice | |
| CN103734727A (en) | Donkey-hide gelatin sea cucumber and preparation method thereof | |
| CN105942069A (en) | Spirulina health-care beverage with immunity enhancing function and preparation method thereof | |
| CN105124338A (en) | Health care and beauty fruit and vegetable sauce and making method thereof | |
| KR100611557B1 (en) | Health drink composition mainly containing barley sprout | |
| CN106174011A (en) | A kind of nutrient formulation nano-particle preventing and treating diabetes and preparation processing method | |
| KR101195455B1 (en) | The composition of the pill-type anchovy and manufacturing process of the same | |
| CN105613898A (en) | Glutathione lemon tablet candy and preparation method thereof | |
| CN107439856A (en) | A kind of nutrient health fruit-vegetable juice beverage with healthcare function and preparation method thereof | |
| CN106262801A (en) | A kind of nutrient formulation nano-particle preventing and treating thrombophlebitis and preparation processing method | |
| CN104366459A (en) | Preparation method of water lily health capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150114 |